Static Chart Monte Rosa Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-14 EDT			5-day change	1st Jan Change
9.840 ^USD	-0.51%		-3.24%	-37.24%

10-12	UBS Adjusts Price Target on Monte Rosa Therapeutics to $19 From $17, Maintains Buy Rating	MT
10-01	Monte Rosa Therapeutics Announces Positive Data From GFORCE-1 Phase 1 Study Evaluating MRT-8102	CI

Duration

Period